2016•Pacific Asia Conference on Information SystemsRequires access

THE EFFECT OF INNOVATION STRATEGY ON POST-M&A INNOVATION PERFORMANCE: AN EVIDENCE FROM PHARMACEUTICAL INDUSTRY

Chun-Mao Chang, Chih‐Ping Wei

Open publisher page 1 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Business, Innovation management, Pharmaceutical industry, Knowledge management, Industrial organization, Manufacturing engineering, Computer science, Marketing

Back to paper search Browse research topics Original source

THE EFFECT OF INNOVATION STRATEGY ON POST-M&A INNOVATION PERFORMANCE: AN EVIDENCE FROM PHARMACEUTICAL INDUSTRY — Research Paper | ScholarLens